Regulation of CD4 T cell tolerance by the NR4A family of nuclear receptors
Regulation of CD4 T cell tolerance by the NR4A family of nuclear receptors
批准号:
10707222
负责人:
JULIE ZIKHERMAN
金额:
$58.77万
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-09-19 至 2027-07-31
关键词:
AcuteAgonistAnti-Inflammatory AgentsAntigensAutoantibodiesAutoantigensAutoimmune ResponsesB-Cell ActivationB-LymphocytesBCL2L11 geneBacterial Artificial ChromosomesBiologyBone MarrowBypassCD4 Positive T LymphocytesCell CompartmentationCell Death InductionCellsChimera organismChronicClonal DeletionCoupledDNA Binding DomainDataDiseaseEpigenetic ProcessExhibitsFOXP3 geneFamilyFamily memberGene ExpressionGene Expression ProfileGenesGeneticGenetic TranscriptionGenomic approachGoalsHomeostasisImmuneImmune responseImmunosuppressionImpairmentInflammatoryInterleukin-2KnowledgeLigandsLymphocyteMediatingMolecularMusNR4A1 geneNR4A2 geneNuclearNuclear FamilyNuclear Hormone ReceptorsNuclear ReceptorsOrgan TransplantationOrphanPatternPeripheralPhenocopyPhenotypePhysiologicalPlayProductionProliferatingPublishingRadiation ChimeraRegulationRegulatory T-LymphocyteReporterRepressionRoleSignal TransductionT cell anergyT cell responseT-Cell DevelopmentT-LymphocyteTestingTherapeuticThymus GlandTissuesTranscriptional RegulationVaccinationanergyantagonistantigen-specific T cellsautoreactive T cellchromatin remodelingcytokinedefined contributionexhaustexpectationgenetic approachinnovationmembernon-genomicnovelnovel therapeuticspreservationprogramsresponserestraintsmall moleculethymocytetranscription factortranscriptometranscriptome sequencingtumor
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary/Abstract
This proposal’s long-term goal is to take advantage of the biology of the NR4A family of orphan nuclear hormone
receptors to selectively manipulate antigen-specific T cell responses in immune-mediated diseases.
NR4A members (NUR77, NURR1, and NOR1) are encoded by three genes (Nr4a1-3, respectively) that are
rapidly induced by antigen (Ag) stimulation in lymphocytes. Although they are thought to function as ligand-
independent, constitutively active transcription factors, small molecule agonist and antagonist ligands have been
developed, rendering them druggable. We and others have shown that NR4A TF expression scales with the
intensity of Ag stimulation, and are highly upregulated in thymocytes undergoing negative selection, in regulatory
T cells (Tregs), as well as in self-reactive, anergic, or exhausted T cells. Due to an overlapping expression pattern
and considerable structural homology in their DNA-binding domain, the NR4A TFs exhibit profound functional
redundancy; thymic deletion of multiple - but not individual - NR4A family members (Nr4a1 and Nr4a3 >> Nr4a2,
which is minimally expressed) results in severe Treg deficiency and a “scurfy-like” disease that phenocopies
Foxp3-/- mice. Consequently, it has not been possible previously to unmask additional redundant functions of
this family during thymic selection and in conventional mature CD4 T cells (Tconv). This represents a major gap
in our knowledge that limits full therapeutic exploitation of these factors.
Recently, we took advantage of both conditional genetic and bone marrow chimera strategies in order to preserve
Treg homeostasis. Unexpectedly, mixed chimeras harboring both WT and Nr4a1-/- Nr4a3-/- (DKO) bone marrow
rapidly develop anti-nuclear autoantibodies (ANAs) and a systemic inflammatory disease despite a replete Treg
compartment of largely WT origin. This disease differs qualitatively from that seen in germline DKO mice with
Treg-deficiency, and is B cell-extrinsic. We show that negative selection of DKO thymocytes is profoundly
impaired in a cell-intrinsic manner. Consistent with escape of self-reactive T cells into the periphery, DKO CD4
Tconv cells expressing phenotypic and transcriptional markers of anergy accumulate in these chimeras.
However, these self-reactive DKO cells nevertheless exhibit exaggerated proliferation and IL-2 production,
suggesting that functional anergy is defective. We therefore hypothesize that the NR4A family play cell-intrinsic,
but redundant, roles in both central and peripheral CD4 T cell tolerance. To test this hypothesis:
In our first aim, we propose to define the role of the NR4A family in thymic negative selection in the face of both
ubiquitous and tissue-restricted antigens, and to define the transcriptional targets that contribute to this function.
In our second aim, we propose to isolate NR4A contributions to peripheral T cell tolerance, and to canonical
features of mature CD4 T cell anergy - including impaired signal transduction, cytokine production, and
proliferation. We will use both bulk and single cell genomic approaches to define the mechanism by which the
NR4A family regulates the transcriptome and epigenetic profile of naïve and tolerant CD4 T cells.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Regulation of CD4 T cell tolerance by the NR4A family of nuclear receptors
-
批准号:10599024
-
项目类别:
-
资助金额:$60.31万
-
财政年份:2022
-
负责人:JULIE ZIKHERMAN
-
依托单位:
Nuclear Receptors in B Cell Tolerance and Humoral Immune Responses
-
批准号:10626756
-
项目类别:
-
资助金额:$40.38万
-
财政年份:2020
-
负责人:JULIE ZIKHERMAN
-
依托单位:
Nuclear Receptors in B Cell Tolerance and Humoral Immune Responses
-
批准号:10410354
-
项目类别:
-
资助金额:$40.38万
-
财政年份:2020
-
负责人:JULIE ZIKHERMAN
-
依托单位:
Nuclear Receptors in B Cell Tolerance and Humoral Immune Responses
-
批准号:10192648
-
项目类别:
-
资助金额:$40.38万
-
财政年份:2020
-
负责人:JULIE ZIKHERMAN
-
依托单位:
Dissecting unique functions of IgM and IgD BCRs in tolerance and autoimmunity
-
批准号:9193713
-
项目类别:
-
资助金额:$34.87万
-
财政年份:2016
-
负责人:JULIE ZIKHERMAN
-
依托单位:
Dissecting unique functions of IgM and IgD BCRs in tolerance and autoimmunity
-
批准号:9899730
-
项目类别:
-
资助金额:$34.87万
-
财政年份:2016
-
负责人:JULIE ZIKHERMAN
-
依托单位:
Dissecting unique functions of IgM and IgD BCRs in tolerance and autoimmunity
-
批准号:9479603
-
项目类别:
-
资助金额:$34.87万
-
财政年份:2016
-
负责人:JULIE ZIKHERMAN
-
依托单位:
Titrating CD45 expression in mice to study development of T cell tolerance
-
批准号:8098871
-
项目类别:
-
资助金额:$11.96万
-
财政年份:2010
-
负责人:JULIE ZIKHERMAN
-
依托单位:
Titrating CD45 expression in mice to study development of T cell tolerance
-
批准号:8701864
-
项目类别:
-
资助金额:$11.96万
-
财政年份:2010
-
负责人:JULIE ZIKHERMAN
-
依托单位:
Titrating CD45 expression in mice to study development of T cell tolerance
-
批准号:7952505
-
项目类别:
-
资助金额:$11.96万
-
财政年份:2010
-
负责人:JULIE ZIKHERMAN
-
依托单位:
Titrating CD45 expression in mice to study development of T cell tolerance
-
批准号:8282638
-
项目类别:
-
资助金额:$11.96万
-
财政年份:2010
-
负责人:JULIE ZIKHERMAN
-
依托单位:
Titrating CD45 expression in mice to study development of T cell tolerance
-
批准号:8494380
-
项目类别:
-
资助金额:$11.96万
-
财政年份:2010
-
负责人:JULIE ZIKHERMAN
-
依托单位:
国内基金
海外基金
Agonist-GPR119-Gs复合物的结构生物学研究
-
批准号:32000851
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:乔安娜
-
依托单位: